Bicarbonate drink could reduce emergency C-Sections in prolonged labour
NCT ID NCT07321379
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests whether a single dose of oral bicarbonate can reduce the need for assisted delivery (emergency C-section or vacuum/forceps) in first-time mothers with prolonged labour. 1520 women will be randomly assigned to receive bicarbonate or a placebo. After two hours, if labour hasn't progressed, standard oxytocin treatment is given. The study also tracks birth experience and newborn health.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- sodium bicarbonate
- What this could lead to
- If it works, this could offer a simple, low-cost way to reduce emergency C-sections and vacuum/forceps deliveries in prolonged labour.
- What could go wrong
- This is an early-stage trial with no prior human data for this use. The effect may be small or none, and results may not apply to all women.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 1,520 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Feb 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥18 years. * Danish or English speaking. * Cephalic presentation. * Gestational age ≥34+0 - \<42+0 (days +weeks) at onset of labour. * Normal foetal heart rate pattern in the 20 minutes prior to inclusion. * Spontaneous onset of labour or non-medical induced labour (balloon catheter and/or artificial rupture of membranes). * Active first stage of labour confirmed, according to Danish national guidelines: Cervical dilatation at ≥4 - \<10 cm with regular painful contractions. * Prolonged labour diagnosed, according to Danish national guidelines: Cervical dilatation progresses at less than 2 cm over a 4-hour period. Exclusion Criteria: * Clinical suspicion of infection (2 confirmed temperatures ≥38.5°C with epidural, ≥38 °C without epidural, or broad-spectrum antibiotics initiated) * Significant medical comorbidity in the form of renal or heart condition, assessed case-by-case basis. * Serious obstetric complication * Known allergy or intolerance to sodium bicarbonate. * Ingestion of sodium bicarbonate in active labour prior to inclusion. * Current treatment with following medicines: Gabpabpentin, Tetracycline, Ketoconazole (NB! These medications are already generally advised contradicted against induring pregnancy)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Labor dystocia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Aarhus University Hospital
Aarhus, 8200, Denmark
-
Copenhagen University Hospital, Hvidovre
Copenhagen, Denmark
-
Copenhagen University Hospital, Rigshospitalet
Copenhagen, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.